A detailed history of Integrated Wealth Concepts LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Integrated Wealth Concepts LLC holds 17,158 shares of IBRX stock, worth $44,953. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,158
Previous 17,158 -0.0%
Holding current value
$44,953
Previous $108,000 41.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.82 - $9.15 $82,701 - $156,995
17,158 New
17,158 $108,000
Q3 2023

Nov 15, 2023

SELL
$1.29 - $3.1 $6,385 - $15,345
-4,950 Reduced 26.82%
13,508 $22,000
Q2 2023

Aug 15, 2023

BUY
$1.53 - $6.41 $76 - $320
50 Added 0.27%
18,458 $51,000
Q1 2023

May 03, 2023

BUY
$1.35 - $4.78 $24,850 - $87,990
18,408 New
18,408 $34,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.05B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Integrated Wealth Concepts LLC Portfolio

Follow Integrated Wealth Concepts LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.